How can I conduct pre‑eclampsia problem‑based learning in primary care for a pregnant woman in her first or second trimester who has risk factors such as nulliparity, chronic hypertension, pre‑gestational diabetes, renal disease, obesity, or a prior episode of pre‑eclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Conducting Pre-Eclampsia Problem-Based Learning in Primary Care

Structure your pre-eclampsia problem-based learning session around the PRECOG guideline's three-phase algorithmic approach: early risk assessment (before 20 weeks), risk stratification with specialist referral criteria, and systematic post-20-week surveillance—this evidence-based framework directly addresses the maternal and perinatal mortality that occurs in 46% of maternal and 65% of fetal deaths when risk factors are missed 1.

Phase 1: Early Pregnancy Risk Assessment (Before 20 Weeks)

Begin your PBL case by having learners systematically identify risk factors at the first prenatal visit. The PRECOG guideline provides quantified relative risks that should guide your teaching 1:

High-Priority Risk Factors (Require Immediate Specialist Referral)

Present cases where learners must recognize these conditions that mandate specialist input before 20 weeks 1:

  • Previous pre-eclampsia (RR 7.19) - highest single historical risk factor
  • Pre-existing hypertension or booking diastolic BP ≥90 mm Hg (RR 5.1) 2
  • Pre-existing diabetes (RR 3.56)
  • Pre-existing renal disease or booking proteinuria (≥+ on multiple occasions or ≥300 mg/24h)
  • Antiphospholipid antibodies (RR 9.72) - highest overall risk
  • Multiple pregnancy (RR 2.93)
  • Any two other factors from the moderate-risk list below

Moderate-Risk Factors to Document

Structure case scenarios around identifying 1:

  • Nulliparity (RR 2.91)
  • Age ≥40 years (RR 1.68-1.96)
  • BMI ≥35 (RR 1.55)
  • Family history of pre-eclampsia in mother or sister (RR 2.90)
  • Booking diastolic BP ≥80 mm Hg (even if <90)
  • ≥10 years since last pregnancy

Phase 2: Post-20 Week Surveillance Protocol

Design your PBL cases to teach the systematic assessment required at every prenatal visit after 20 weeks 1. This is where most preventable deaths occur due to failure to recognize warning signs 1.

At Every Assessment, Learners Must Check For:

New hypertension (diastolic BP ≥90 mm Hg in women with BP <90 before 20 weeks) 1

New proteinuria (≥+ on dipstick, protein:creatinine ratio ≥30 mg/mmol, or ≥300 mg/24h) 1

Warning symptoms 1:

  • Headache or visual disturbances
  • Epigastric pain or vomiting
  • Reduced fetal movements
  • Small for gestational age infant

Blood Pressure Measurement Technique

The USPSTF guideline specifies exact technique—incorporate this into your PBL skills station 3:

  • Patient relaxed for 5 minutes before measurement
  • Sitting position with legs uncrossed, back supported
  • Arm at level of right atrium
  • Use large cuff if upper arm circumference ≥33 cm
  • Never measure in left lateral position (falsely lowers readings) 3
  • Confirm elevated readings with repeated measurements

Phase 3: Risk Stratification and Referral Decisions

Create decision-making scenarios where learners must determine appropriate care level. The PRECOG guideline provides a two-tiered monitoring system 1:

Immediate Specialist Referral Criteria

Present cases requiring urgent action when patients develop 1:

  • New hypertension (BP ≥140/90) plus new proteinuria = pre-eclampsia diagnosis
  • Superimposed pre-eclampsia (new features in context of pre-existing hypertension or proteinuria)
  • Any warning symptoms with hypertension or proteinuria

Enhanced Community Monitoring

For high-risk women without active disease, teach the intensified surveillance schedule between 24-32 weeks and 32 weeks to delivery 1.

Prevention Strategies for High-Risk Cases

Incorporate aspirin prophylaxis decision-making into your PBL scenarios 3, 4, 5:

  • Aspirin 150 mg at bedtime (not 81 mg as in older guidelines) starting at 11-14+6 weeks 4
  • Continue until 36 weeks, delivery, or pre-eclampsia diagnosis
  • Only for women at high risk (≥1:100 risk for preterm pre-eclampsia)
  • Do not prescribe aspirin to all pregnant women 4

For women with low calcium intake (<800 mg/day), consider calcium supplementation (1.5-2 g elemental calcium daily) 4.

Key Teaching Points for Clinical Context

Common Pitfalls to Emphasize

Failure to act on risk factors at booking accounts for nearly half of preventable deaths 1. Structure cases where learners must recognize that:

  • A single risk factor (like nulliparity or obesity) requires documentation and heightened surveillance
  • Two moderate risk factors = specialist referral before 20 weeks 1
  • Chronic hypertension has 16% rate of developing pre-eclampsia 2—these women need aspirin and close monitoring

Definitions That Matter

Pre-eclampsia requires both 1:

  • New hypertension (≥140/90) at or after 20 weeks, AND
  • Quantified proteinuria (≥300 mg/24h)
  • Confirmed if resolves after delivery

Superimposed pre-eclampsia = development of pre-eclampsia features in women with pre-existing hypertension or proteinuria 1—this is particularly dangerous and easily missed.

Practical PBL Case Structure

Design your cases with progressive complexity:

  1. Case 1: 32-year-old nulliparous woman, BMI 37 → Learners identify two risk factors, discuss enhanced monitoring
  2. Case 2: 28-year-old with previous pre-eclampsia at 34 weeks → Learners must recommend specialist referral before 20 weeks and aspirin prophylaxis
  3. Case 3: 35-year-old with chronic hypertension presents at 26 weeks with BP 150/95 and trace proteinuria → Learners must recognize superimposed pre-eclampsia risk and arrange urgent assessment
  4. Case 4: 42-year-old with headaches at 32 weeks, BP 145/92 → Learners must systematically assess for pre-eclampsia features and determine referral urgency

The algorithmic approach from PRECOG provides the framework that reduces the 46% of maternal deaths and 65% of fetal deaths that are preventable with proper recognition and response 1. Your PBL session should drill this systematic approach until it becomes automatic clinical practice.

References

Guideline

screening for preeclampsia: recommendation statement.

American family physician, 2018

Research

The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2019

Research

Pre-eclampsia screening in the first trimester - preemptive action to prevent the peril.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022

Related Questions

Which of the following statements about preeclampsia and eclampsia is false?
What are the diagnostic criteria for preeclampsia?
What is the prehospital management of preeclampsia by paramedics?
In a patient with severe preeclampsia and a serum potassium of 5.3 mmol/L, is telemetry monitoring indicated?
What basic information about pre‑eclampsia should I know for the NAC OSCE in Canada?
What is the recommended dosing regimen and safety considerations for semaglutide (Ozempic) injections for weight loss in an adult without contraindications?
Should a 19-year-old with abrasions from a bicycle accident receive a tetanus booster (Tdap/Td)?
A patient taking warfarin 2 mg on Thursday, Saturday, and Sunday and 4 mg on other days has a Wednesday INR of 2.7 and a Thursday INR of 3.0 (target INR 2–3 for atrial fibrillation). Should I give an additional 0.5 mg, 1 mg, or omit the dose today?
How should polyclonal T‑cell receptor gamma (TRG) gene rearrangements (all <2.5% of reads) be interpreted in a patient with hairy cell leukemia, and does this finding require any change in management?
How can I differentiate paranoid personality disorder from delusional disorder, jealous type in a patient?
In a 57-year-old male smoker with macrocytic anemia (MCV 127 fL), leukopenia (WBC 3.4 ×10⁹/L), hemoglobin 10.2 g/dL, hematocrit 28.9 %, platelets 159 ×10⁹/L, and normal thyroid function, what is the most likely diagnosis and what initial workup and management steps should be taken?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.